Antibiotic resistance
Antibiotic resistance means that bacteria are no longer killed by a drug that used to work against them. It arises through random changes in the bacteria's genetic material and spreads when antibiotics are used too often or incorrectly.
Antibiotics are drugs that kill bacteria or stop them from multiplying. Bacteria are tiny single-celled organisms, some of which cause diseases. Antibiotic resistance refers to a situation where such a drug no longer works against certain bacteria. The patient takes the tablets, yet the pathogens keep multiplying. Importantly, it is not the human who becomes resistant, but the bacteria in their body. If several different drugs become ineffective at once, the pathogens are called multidrug-resistant.
Why routine surgeries can become dangerous again
Antibiotics are a quiet foundation of modern medicine. Without them, artificial hip joints, cancer therapies, or premature-infant wards would hardly be conceivable. In all these cases, the immune system is weakened or a wound is open. One relies on being able to stop an emerging infection with medication if necessary. If this safeguard disappears, a minor procedure turns into a real risk.
The numbers are already stark today. Estimates suggest that more than a million people worldwide die every year from infections with resistant pathogens. In Europe, the figure stands at several tens of thousands of deaths per year. The World Health Organization counts antibiotic resistance among the greatest threats to global health.
At the same time, hardly any new active substances are coming onto the market. For pharmaceutical companies, antibiotics are economically unattractive because they are only taken for a few days. A blood pressure medication, by contrast, is taken by the same patient for decades. New antibiotics are also deliberately held back so they don’t quickly become ineffective. Whoever develops them thus earns little precisely when they do it right.
How bacteria learn to survive the drug
Bacteria multiply extremely fast; some divide every twenty minutes. With each division, random errors occur in the genetic material, i.e., in the cell’s blueprint. Most of these errors are useless or harmful. However, a few change exactly the spot where an antibiotic attacks. This bacterium survives the treatment while its relatives die.
This is where selection begins. The survivor suddenly has unlimited space and food and multiplies unhindered. After a short time, the entire population consists of resistant offspring. The antibiotic thus does not create the resistance; it merely consistently sorts out all susceptible bacteria. This is precisely why frequent and unnecessary use is the core problem.
There is also a special feature: bacteria can pass resistance genes directly to neighbors, even to foreign species. A harmless gut bacterium can thus transfer its resistance to a dangerous pathogen. A common misconception, incidentally, is that antibiotics help against flu or the common cold. These are caused by viruses, and viruses are not bacteria. Such prescriptions do no good and, on top of that, breed resistance.
From the family doctor’s office to the pig barn
In everyday life, the term is most often encountered at the doctor’s office. When a doctor doesn’t prescribe an antibiotic for a sore throat, this very consideration is often behind it. The advice to finish a full course of medication also stems from this. Another well-known example is MRSA, a hospital germ against which many standard medications fail. Strict hygiene rules and disinfectant dispensers in clinics are a direct response to this.
A large share of all antibiotics is not used on humans at all, but in animal farming. When entire herds are treated preventively, resistant germs develop there and reach us via meat or manure. This is why resistance regularly appears in news about agriculture and food safety.
In tech and finance news, the topic appears from a different angle. Biotech companies use computer models to search for new drug candidates, for instance by having software calculate through millions of possible molecules. At the same time, governments are discussing incentive payments meant to make the development of new antibiotics economically worthwhile. Antibiotic resistance is thus no longer just a medical issue, but an economic one as well.